The Market Reports

Synopsis
The global market for Cell Banking Outsourcing was estimated to be worth US$ 9372 million in 2024 and is forecast to a readjusted size of US$ 26485 million by 2031 with a CAGR of 16.1% during the forecast period 2025-2031.
Cell Banking Outsourcing refers to the practice of delegating the critical processes of collecting, processing, expanding, and storing cell samples—such as stem cells, immune cells, or genetically engineered cells—to specialized third-party service providers. This service involves standardized GMP-compliant biobanking procedures, stringent quality control, and full lifecycle data traceability. With the rapid expansion of precision medicine, cell therapies, and biopharmaceutical R&D, outsourced cell banking is becoming a vital infrastructure across the global healthcare and life sciences industries, bridging the gap from clinical research to commercial application.
The global biopharmaceutical sector is undergoing structural transformation, with emerging therapies such as cell and gene therapy driving a surge in demand for large-scale, high-quality cell sample banking. Biotech companies are increasingly favoring asset-light R&D models, outsourcing cell banking, QC, and storage to specialized providers with GMP or ISO certifications to enhance efficiency and reduce operational burden. Meanwhile, national policies in countries like China, the U.S., South Korea, and Singapore continue to prioritize cell banking as a strategic infrastructure initiative. These factors jointly propel the Cell Banking Outsourcing market into a high-growth trajectory, attracting both capital and industry attention as a critical enabling service. Despite strong demand, the sector faces considerable hurdles. Global disparities in regulation—especially in areas such as sample cross-border transfer, ethical approvals, and data sovereignty—present compliance complexities. The industry has high entry barriers, requiring significant investment in infrastructure, certified personnel, and quality systems. Client expectations around data integrity, biosafety, and long-term storage reliability are also rising, leading to market consolidation. As a result, while leading providers strengthen their positions, smaller players face increasing operational and competitive pressures.Demand is shifting from early-stage academic and research applications to late-phase and commercial clinical programs, especially in CAR-T, iPSC-based regenerative therapies, and personalized immunotherapies. Phase III+ trials require stricter sample handling and storage protocols. Additionally, global pharma and CRO/CMO players are reshaping their supply chains, driving the adoption of multi-site collection, regionalized biobanking, and real-time digital traceability systems. The future will favor providers offering integrated, automated, and fully compliant services—emerging as platform-centric and ecosystem-leading companies in a rapidly maturing landscape.
This report aims to provide a comprehensive presentation of the global market for Cell Banking Outsourcing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell Banking Outsourcing by region & country, by Type, and by Application.
The Cell Banking Outsourcing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Banking Outsourcing.
Market Segmentation
By Company
SGS Life Sciences
Lonza
CCBC
Vcanbio
AMAG Pharmaceuticals
ViaCord
Thermo Fisher
Wuxi Apptec
CordLife
Esperite
Reliance Life Sciences
Lifecell
Cryo-Cell
Toxikon
Goodwin Biotechnology
Texcell
Cryo Stemcell
Segment by Type
Stem Cell Banking
Non-stem Cell Banking
Segment by Application
Cell Bank Storage
Bank Characterization and Testing
Cell Bank Preparation
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cell Banking Outsourcing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cell Banking Outsourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cell Banking Outsourcing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index